Veeva sfa. Subjects with bilateral, SFA/PPA disease (i.

Veeva sfa However, available data from human dietary intervention studies is limited and these studies did not reflect a realistic diet. Diagnostic Test: High-frame-rate contrast The purpose of the study is to evaluate the safety and efficacy on the use of drug eluting balloon (DEB) with paclitaxel to treat in-stent restenosis in femoropopliteal arteries. Stenosis and/or occlusion often can occur by 6 months. The research-based pharmaceutical company had been using a hosted SFA system for the previous This engineer will be responsible for China SFA's application development of our SaaS cloud products. This allows users to quickly display content during meetings and navigate between their presentations and call reports. Major distal amputation. As one of the fastest-growing SaaS companies in history, we surpassed $2B in revenue in our last fiscal year with extensive growth potential ahead. one SFA/PPA lesion per limb) are eligible for enrolment into the study. China - Chengdu. Skip to main content Salesforce Marketing CloudとVeeva CRMとの新たな統合、Veeva VaultにおけるSalesforce Service Cloudのサポート開始を発表 Salesforce社で会長兼CEOを務めるMarc Benioff氏 「この10年間、Veeva社は我が社にとって貴重なパートナーであり、Peter Gassner氏はそのCEOとして極めて優れた手腕を発揮してきました。」 Veeva CRMと This study evaluates the local inflammatory and resolution response of patients undergoing peripheral vascular intervention like an angioplasty of the superficial femoral artery (SFA) or popliteal artery, or stenting of the iliac artery or SFA, through the use of Positron emission tomography-magnet The organization has replaced its SFA system with Veeva CRM™ from Veeva Systems, the leader in SaaS solutions for the global life sciences industry. 6; Computed Tomographic Angiography (CTA) confirming at least a 50% SFA stenosis with moderate to severe calcification; or; Magnetic Resonance Angiography (MRA) confirming at least a 50% SFA or below the knee stenosis with moderate to severe calcification. When a submission is imported, Subjects will undergo a superficial femoral artery (SFA) stent procedure using the Misago™ Peripheral Self Expanding stent once all of the inclusion and none of the exclusion criteria are met. Two locations along the vascular tree at which atherosclerotic plaques are typically found are the carotid artery (CA) Veeva China SFA (Industry cloud for life sciences) is a a CRM solution that StatusGator has been monitoring since November 2019. The main objective of this study is to assess the patency rate of the nitinol self-expandable stent device in the treatment of superficial femoral artery (SFA) occlusions as compared to angioplasty only. The investigators registered presence of varicose veins, type of previous invasive procedure and availability of saphenous trunks as possible Veeva Fast Facts Proven pioneers of cloud-based technology, Accenture and Veeva are teaming to develop customer Force Automation (SFA) Accenture has created a dedicated global factory that provides high-quality, cost-effective and industrialized delivery in Question: What are common acronyms used in Veeva CRM? Answer: AE - Approved Email AOC - Acknowledgement of Content API - Application Programming Interface ATL - Account Territory Loader B Percutaneous transluminal angioplasty (PTA) is a minimally invasive technique for treatment of superficial femoropopliteal artery (SFA) obstructions or occlusions in patients with intermittent claudication as well as critical limb ischemia. Details and patient eligibility. Demographic data and medical history were taken. Read the latest reviews, pricing details, and features. 5 mg/dL within 45 days prior to study procedure. com。 Veeva Responsible for all aspects of implementation and ongoing support for the Salix Veeva SFA system. Bifurcational lesions of the CFA and lesions including the first 3 cm of the SFA, due to technical aspects of FMD measurement; Requiring stent implantation in the PA; Instent-Restenosis; Thrombolysis within 72 Hours prior to the index procedure; Aneurysm formations in the femoral artery or popliteal artery Since the length of lesion seems to be negatively associated with stent patency due to restenosis, it is thought that the efficacy of treatment in patients with multiple (> 1) short (focal; > 1 and < 5 cm) SFA lesions can be improved by spot stenting as compared to the use of one long stent. e. 5 mm within the SFA/PPA, estimated visually. Stable medical condition. There is no cure for psoriasis and treatment is directed at controlling patients' symptoms. Event Management Our Trade Show module, made available Excessive consumption of fats enriched in saturated fatty acids (SFA) is associated with an increased risk of atherosclerosis and other CVD. This is a prospective, multicenter, non-randomized, single arm, pivotal trial. To further expand these efforts, Veeva is now establishing a Customer Success Management (CSM) team that will work alongside our product, sales, and services teams to help customers achieve even higher levels of success. S. Interventional. Subject is willing and able to provide informed consent and comply with study procedures and required follow-up evaluations. Device: SeQuent Please This is a prospective, nonrandomized, single-arm study using the Zilver PTXTM stent in patients with Superficial Femoral Artery (SFA) disease (total occlusions or significant stenosis). Apply for this job. iPad; To facilitate their own custom navigation over standard navigation and allow the CLM media player to be more compatible with layered content, admins can disable the navigation bar and history buttons and define navigation behavior for individual slides. The best GoGreen Sales Force Automation (SFA 360) alternatives are Scilife, Ideagen PleaseReview, and Veeva Vault. The stent efficacy and safety will be evaluated immediately post procedure, and at 30 days, 6, 12, 24, and 36 months post procedure. The Source Reference is the relationship between Submissions Archive documents and the source file in Submissions. Veeva’s core values — do the right thing, customer success, employee success, and speed — guide our decision making and define our culture. China - Dalian. Psoriasis is a common chronic skin disorder that affects over 4 million people. It connects sales, marketing, The superficial femoral artery (SFA) has been the region most difficult to treat and maintain patency. The research-based pharmaceutical company had been using a hosted SFA system for the previous This global biopharmaceutical company had been using 10 different client/server SFA systems throughout its worldwide operations. PLEASANTON, CA — April 26, 2022 – Veeva Systems (NYSE: VEEV) today announced Veeva Data Cloud, a group Despite work showing the overconsumption of saturated fatty acids (SFA) to be metabolically deleterious, debate continues about whether there is a link between SFA and cardiovascular disease risk. As users progress through slides within a presentation, a browser-like history is saved. The contralateral SFA/PPA intervention may be performed at the time of the index procedure (prior to treatment of study lesion); however, the use of an The investigators propose to evaluate the effects of avocado consumption (by incorporating 1 unit of fruit per day into a healthy diet) on multiple cardiovascular disease (CVD) risk factors. It is cut from a nickel titanium alloy (Nitinol) tube and consists of a series of segments each connected Planed Indications for use: The Jetstream System is intended for use in atherectomy of the peripheral vasculature and to break apart and remove atherosclerotic disease, debris, and automation (SFA) and customer relationship management (CRM) systems dominated the pharmaceutical market. Approved WeChat – Integrated with Veeva CRM, users can communicate with HCPs via WeChat to meet targets and objectives; Approved WeChat on WeCom – Integrating Tencent's WeCom client with users' personal Total occlusion of the SFA or PA in the index leg. View 3 locations. The action menu is available when displaying content in Slide Show View, Window View, and Presenter View. Clinical Solutions Veeva Development Cloud; Veeva Clinical Platform; Clinical Operations; Vault eTMF Stay inspection ready; Vault CTMS Manage trials end-to-end; Vault Payments Pay clinical research sites faster; Vault Study Startup Accelerate site activation; Vault RTSM Randomization and supply management; Veeva Site Connect Automate Prospective, multi-center 1:1 randomized trial to compare efficacy and safety of a stent-avoiding (using drug coated balloons) versus a stent-preferred (using drug eluting or interwoven stents) approach for treatment of complex femoropopliteal lesions TASC The superficial femoral artery (SFA) is frequently involved in atherosclerosis and is the most common target of lower extremity endovascular procedures performed in patients with claudication. Funder types. Common data architecture helps connect sales, medical, and marketing for commercial excellence. stenting of the superficial femoral artery supplemented with fasciotomy in Hunter canal in patients with steno-occlusive lesion of the femoro-popliteal segment of The purpose of this study is to determine the safety, metabolism and potential effect of drug product SFA004 on mild to moderate chronic plaque psoriasis. The research-based pharmaceutical company had been using a hosted SFA system for the previous Using WeChat with Veeva CRM. How dietary fat sources affect satiety, appetite and energy use is The objective was to test the effect of acute elevation of NEFA enriched with either saturated fatty acids (SFA) or SFA with long-chain n-3 polyunsaturated fatty acids (LC n-3 PUFA) on postprandial vascular function measured via flow-mediated dilatation (FMD), laser Doppler iontophoresis (LDI) and digital volume pulse (DVP), followed by a Subjects with symptomatic leg ischemia, requiring treatment of SFA or popliteal (P1 segment) artery; De novo or restenotic lesion(s) >70% within the SFA and popliteal arteries in a single limb which are ≥3 cm and ≤15 cm in cumulative total length (by visual estimation). Status. The overall goal of this multicenter collaborative research study is to identify genetic, proteomic, and/or lipidic (lipidomic) biomarkers associated with the outcomes of lower extremity revascularization in patients with advanced peripheral artery disease (PAD). In the present study a combination of low GI/SFA on the one hand and high GI/SFA on the Excessive consumption of fats enriched in saturated fatty acids (SFA) is associated with an increased risk of atherosclerosis and other CVD. 4492E . Other. As one of the fastest-growing SaaS companies in history, we surpassed Milk fat contains large amounts of medium-chain saturated fatty acids (MC-SFA), which may have beneficial effects on human health. Use of atherectomy devices or other adjunctive treatment in the SFA/PPA during the index procedure; History of major amputation in the same limb as the target lesion; Life expectancy less than 12 months due to other medical co-morbid condition(s) that could limit the subject's ability to participate in the clinical study, limit the subject's The present study will aim to assess the effectiveness of the non-Incised Papilla surgical approach NIPSA used for the surgical debridement of deep intraosseous defects compared to the single-flap approach SFA. Over the past about 5 years, we have collected data on on more than 2,184 outages that affected Veeva China SFA users. The purpose of this study is to evaluate the effect of dietary fat on satiety (the experience of fullness between one meal and the next) and energy metabolism over an extended period of time (chronic effects). Veeva To determine whether the Boston Scientific nitinol drug-eluting stent shows acceptable performance at 9 months when treating Superficial Femoral (SFA) and/or Proximal Popliteal Artery (PPA) lesions. Veeva Vault is a unified suite of applications that delivers a single source of truth for regulated content and data across the enterprise. Patients will be followed for 24 months post-procedure, with all patients having duplex ultrasound and clinical assessments at discharge, 1, 6, 9, 18 and 24 The primary objective of this study is to confirm the safety and efficacy of the RenzanTM Peripheral Stent System when used for treatment of superficial femoral (SFA) and/or popliteal (POP) artery disease. Female subjects only: If female, then subjects of childbearing potential must have a negative pregnancy test ≤ 7 days before the SFA and/or popliteal artery had severe stenosis (stenosis degree ≥70%) or occlusion. 6. Serum creatinine > 2. The main objective of this study is to demonstrate the safety and effectiveness of the IDev SUPERA® Nitinol Stent System in treating subjects with obstructive superficial femoral Veeva OpenData is global reference data of healthcare professionals and healthcare organizations. This role provides offsite, post-implementation services to China's domestic customers. Sham cerebellar tDCS plus SFA for 15 sessions (25-minutes per each 60-minute treatment session) over the course of 3-5 weeks. Restenosis. 0 - 6. 9 (If ABI>1. Subjects will be treated with the LUTONIX Drug Coated PTA Dilatation Catheter carrying the Feasibility Study of the Vessel Restoration System (VRS) for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Popliteal Artery (PA) after Sub-optimal percutaneous transluminal angioplasty (PTA) or Atherectomy: REACTIVATE I The objective of this study is to evaluate the immediate and long-term (up to 12 months) safety and effectiveness of primary stenting with the Protégé Everflex+ stent system for the treatment of superficial femoral artery (SFA) lesions (without involvement of the popliteal artery) between 40 mm and 180 mm in length. Endovascular treatment of SFA is challenging, given its exceptional predisposition to atherosclerosis and The registry will enroll patients with claudication or ischemic rest pain and an angiographically significant lesion in the superficial femoral or popliteal artery. Guidewire must cross lesion(s) within the true lumen, without a sub-intimal course by physicians performed, based on visual estimate Ninety (90) patients with de novo or restenotic native SFA lesions will be randomized to the Sirolimus Coated SMART™ nitinol self-expanding stent or to the uncoated (bare) SMART™ stent. The available actions include: Next Slide – navigates one slide forward Given these findings, this study will examine the postprandial effects of meals with 2 levels of saturated fatty acids (SFA) on metabolic endotoxemia, inflammation and satiety, using a randomized cross-over design. The tides have changed and now the vast majority of 沪icp备 10220842号-6 ｜ 沪公网安备 31010602006042号 沪公网安备 31010602006042号 One of Veeva’s newest customers, a top 50 Pharma company can attest to this fact. Veeva China SFA 6. Question: What are common acronyms used in Veeva CRM? Answer: AE - Approved Email AOC - Acknowledgement of Content API - Veeva Customers can get answers to common issues or problems, participate in the Product Communities, submit product enhancement requests, and submit tickets to Veeva Product Support. Device: Nitinol stent. The length of target lesion less than 20 cm; Subject (or legal guardian) understands the study requirements and procedures and provides written Informed Consent All subjects between 18 and 80 years of age with symptomatic claudication (Rutherford category 1-6) with TASC II type A, B, or C lesions will be invited to participate (23, 24). 5 cm of the SFA / PFA bifurcation. one SFA/PPA lesion per limb) are eligible for enrollment into the study. Peripheral Arterial Disease. The prevalence of its milder symptomatic manifestation, intermittent claudication among 40 Fortrea is adapting to more complex studies and streamlining their data ingestion, cleaning, and review with Veeva CDB. Stenosis. Research is needed to clarify the association between dietary fatty acids and metabolic risk markers beyond lipid profile. com。 Veeva Product Support Engineer - SFA. The substitution of polyunsaturated fatty acids (PUFA) for saturated fatty acids (SFA) is a cornerstone of worldwide dietary advice for coronary heart disease (CHD) risk reduction. NCT02916524. Sampling; CCG’s connectors with Veeva SFA allow for order extract and returning outcomes based upon fulfillment activity. Anatomical criteria: Using the Action Menu in Veeva CRM on Desktop. Senior Back-End Engineer. Veeva Vault for Compliant Content to Salesforce Service Cloud. 300 patients with femoral bifurcation lesions will be included and divided into 3 This is a Belgian prospective multicentre registry to evaluate safety and performance of the Sinus-Superflex-Visual stent (Optimed) in Superficial Femoral Artery (SFA) atherosclerotic lesions. If SM-01 is used in a PTA-bailout patient, the case will be assessed separately. As secondary aim this study is Updates to the Sunrise bar improve efficiency and navigation in the Veeva CRM application. By contrast, replacement of SFA with monounsaturated fatty acids (MUFA) and omega-3 long-chain polyunsaturated fatty acids (ω-3 PUFA) has been reported to be inversely associated with risk of atherosclerosis. The main objective is to evaluate the safety and efficacy of SM-01 stenting (Cordis S. The purpose of the study is to demonstrate the safety and efficacy of the IN. Products . A The purpose of this study is to evaluate the safety and effectiveness of the Jetstream Atherectomy System for the treatment of Japanese patients with symptomatic occlusive atherosclerotic lesions in native superficial femoral artery (SFA) and/ or proximal popliteal arteries (PPA). veeva. No underlying medical condition is present which would prevent the subject from performing the required testing or from completing the study. (presence of fluoroscopic evidence of calcification: 1) on parallel sides of the vessel and 2) extending ≥ 50% High rates of de novo lipogenesis (DNL) and high saturated fatty acid (SFA) fraction in the liver both have been associated with poor metabolic health and hepatic insulin resistance. Identifiers. is a leader in cloud-based software for the global life sciences industry. In addition, milk proteins and in particular whey proteins have been shown to have a beneficial effect on glucose disposal as well as Users can display and navigate CLM content using the built-in media player in the Veeva CRM app. Initial technical The organization has replaced its SFA system with Veeva CRM™ from Veeva Systems, the leader in SaaS solutions for the global life sciences industry. Patients with PAD having superficial femoral artery (SFA) occlusion were consecutively enrolled. At least Veeva OpenData is global reference data of healthcare professionals and healthcare organizations. Pharma has come under intense pressure to remain competitive, hindered to a large extent by hugely expensive and grossly inflexible client-server SFA systems incapable of handling An Early Feasibility Study to Assess Safety and Efficacy of the ChampioNIR® SFA Stent in the Treatment of Patients with Femoro-Popliteal Disease The Complete Self-Expanding (SE) SFA Stent is designed to be a permanent implant. Required stent placement (in the target or any other lesion) across or within 0. To explore this, we are undertaking a human in vivo parallel-design study, comparing two isocaloric hi Gartner defines sales force automation platforms as AI-augmented tools supporting automation and capture of sales activities, processes and administrative tasks, facilitating initiation, engagement and documentation of buyer-seller interactions through multiexperience and channel-agnostic approaches and devices. A. Any previously known coagulation disorder. Rijnstate Hospital. Rep Confirmation files are pushed through the connector so that reps can make available inbound shipment of product as soon as they are received. Current will be administered in a ramp-like fashion, but after the ramping, the intensity will drop to 0 mA. Interestingly, the end product of DNL is mainly SFA. If the user is inactive on a slide for more than three seconds, the button is hidden. Worked closely with end users, business stakeholders, and Veeva Managed Services to coordinate and Using the Arrow Buttons. Find top-ranking free & paid apps similar to GoGreen Sales Force Automation (SFA 360) for your Pharma and Biotech Software needs. Evidence of significant SFA disease involving the most symptomatic limb established by noninvasive vascular testing (ankle-brachial index [ABI] <0. Target vessel reference diameter ≥3 mm and ≤7 mm (by visual Veeva China SFA 6. T. 4, SFA systolic acceleration time >140 milliseconds); computed tomographic angiography, or magnetic resonance angiography confirming at least a 60% stenosis of the SFA. Deep vein thrombosis within the past 3 months. The target lesion will be selected at the investigator's discretion based on study eligibility criteria. Veeva Events Management Administrator Training – Veeva CRM Events Management is the single solution to plan and execute all Events across the enterprise, providing seamless control and total visibility of all Salesforce Customer Secure Login Page. M. The Customer Success Manager will provide strategic guidance Behavioral: Semantic Feature Analysis (SFA) Study type. Blood Flow Quantification Near Stented SFA Lesions Using Ultrasound Velocimetry (EchoPIV in SFA) R. Completed. Veeva This study is intended to help establish standard procedures for use of FFR in the peripheral arterial system and to evaluate the correlation of post-procedural FFR values and clinical outcomes in Superficial Femoral artery (SFA) interventions in subjects ages 18 to 79 with PAD. Target number is 500 patients in approximately 11 centres. So far it is unknown whether it is the process of DNL or the accumulation of SFA per se that leads to hepatic insulin resistance. Physical examination and duplex ultrasound were performed. , but there is only one target lesion; All SFA target lesions are to be located with the proximal point at least 2 cm below the origin of the profunda femoris artery. R. Target lesion that is located in a native de novo superficial femoral artery (SFA) or popliteal artery (popliteal artery extends to and ends proximal to the ostium of the anterior tibial artery) Calcification is at least moderate. It needed a single platform that would improve efficiency and effectiveness across the organization as the company’s first product neared the Veeva Vault Safety is a modern individual case safety report (ICSR) management system that supports intake, processing, and submission of adverse events for clinical and post ABI: <0. Atherosclerotic lesion with diameter stenosis ≥70% ii. The main objective of this study is to assess the safety and effectiveness of the Edwards Lifesciences LifeStent nitinol self expandable stent device and its delivery system in the treatment of occlusive superficial femoral artery (SFA) disease by reducing the re-intervention rate as compared to pe Subjects with bilateral, SFA/PPA disease (i. Veeva中国商务产品总经理靳越专题分享《从 “为中国” 到 “懂中国” ，Veeva China SFA的进阶之路— 产品亮点和路线图》，他谈到： “我们需要一个为中国市场设计的China Commercial Veeva China SFA是一款基于企业微信，集业务系统、服务、数据和基础平台为一体的移动CRM产品，它可以持续地帮助中国市场客户解决销售运营、市场推广、医学信息传递、客户主数据 Question: What is the Source Reference in submission Vault? Answer:. ™ Nitinol Stent System) for the treatment of SFA lesions as compared to PTA (balloon angioplasty). This effect is mediated by dietary saturated fat's impact on fasting plasma cholesterol levels. This study proposes to evaluate the endovascular treatment for patients with SFA lesions by Lesions in contralateral SFA/PPA that require intervention during the index procedure, or within 30 days before or after the index procedure; Required stent placement (in the target or any other lesion) via a retrograde approach. Primary outcome: interproximal clinical attachment level gain Secondary outcomes: resid There is a wealth of evidence implicating the important role of blood flow throughout all stages of the process of atherogenesis. Committed to innovation, product excellence, and customer success, Veeva has more than In the SFA space, there are two primary drivers today: going mobile, and broadening access to data and information that can be put in the sales reps’ hands in the field. Disabling Standard Navigation. As Antegrade and retrograde vascular access on the same common femoral artery at the time of the SFA intervention. A total of 100 patients will be included Sequent Please Drug Coated Balloons Versus Primary Stent Application in Long SFA Lesions (SPORTS) I. Life sciences . It contains addresses, emails, specialties, demographics, compliance This randomized comparative effectiveness trial examines whether active manipulation of a key component of semantic feature analysis (SFA) treatment for word-finding difficulty in aphasia improves outcomes. Veeva Systems is a mission-driven organization and pioneer in industry cloud, helping life sciences companies bring Veeva Vault Safety is a modern individual case safety report (ICSR) management system that supports intake, processing, and submission of adverse events for clinical and post The stenotic or occlusive lesion in Superficial Femoral Artery (SFA) and proximal popliteal artery, P1 segment, is considered suitable for stenting. 9, toe brachial Index [TBI] of <0. We recognize a responsibility to customers, employees, environment, and society. Whereas the combined implementation of femoral-popliteal bypass surgery or endovascular revascularization of SFA can increase the likelihood of ulcer healing and avoid multi-stage surgical interventions. China CRM Suite; Veeva是生命科学行业云软件的全球创新者，致力于创新、产品卓越和客户成功，为超过1300家客户提供服务，从世界上大型的制药公司到新兴的生物技术公司。2021年，Veeva成为第一家转换为公共利益公司(Public Benefit Corporation) 的美国上市公司 Age between 18 and 80 years; Patients with peripheral artery disease (PAD), with Rutherford classification between 2 and 5; an occlusion or a minimum grade of stenosisPrimary over 70% in the superficial femoral artery an /or the popliteal artery Target lesion(s) in the SFA or PPA. The primary purpose of this study is to assess safety and efficacy of the Drug Eluting Balloon (DEB) technology for the treatment of the Superficial Femoral Artery (SFA) ischemic obstructive vascular disease in patients presenting with long lesions. Conditions. The purpose of this investigation is to implement a computational model that can predict and optimize training and cross-language The purpose of this study is to evaluate the safety and effectiveness of the Jetstream Atherectomy System for the treatment of Japanese patients with symptomatic occlusive atherosclerotic lesions in native superficial femoral artery (SFA) and/or proximal popliteal arteries (PPA). Comparison of two methods for revascularization of the superficial femoral artery: stenting of the superficial femoral artery vs. How dietary fat sources affect satiety, appetite and energy use is Veeva China SFA基于微信生态打造，与企业微信打通，并融入了丰富了医药行业场景功能。 比如，基于企业微信的信息留存功能，Veeva China SFA对会话数据做进一步分析，可以帮助医药代表快速判断内容的合规性， The underlying reasons for these poor results are not completely clear, but the main arterial segment within the leg, the femoropopliteal artery, appears to be significantly different from other peripheral arteries because the Superficial Femoral Artery (SFA) and Popliteal Artery (PA) that comprise the femoropopliteal artery (FPA) segment This study evaluates the local inflammatory and resolution response of patients undergoing peripheral vascular intervention like an angioplasty of the superficial femoral artery (SFA) or popliteal artery, or stenting of the iliac artery or SFA, through the use of Positron emission tomography-magnet One de novo or restenotic lesion of the SFA/PPA with a cumulative length visually estimated to be ≤24cm; Arteries with reference vessel diameter of 4. PLEASANTON, CA — April 26, 2022 – Veeva Systems (NYSE: VEEV) today announced Veeva Data Cloud, a group Disabling Standard Navigation. Presence of The CVT-SFA Trial is a prospective, multi-center, open, single arm study enrolling subjects with de-novo or post-PTA occluded/stenotic or re-occluded/ restenotic lesions (excluding in-stent lesions) ≤150mm in length in femoropopliteal arteries with reference vessel diameters of 4-6mm, receiving up to two (2) CVT Everolimus-coated PTA Catheters to establish blood flow and to The investigators evaluated whether primary implantation of a self-expanding nitinol stent yielded anatomical and clinical benefits superior to those afforded by percutaneous transluminal angioplasty with optional secondary stenting. Life sciences The History of MMC Pharmaceuticals Ltd dates back from 1987 Started as a Partnership Company Viz Madras Medical Company in 1987, Converted as a Public limited company by name The main objective is to evaluate the safety and efficacy of SM-01 stenting (Cordis S. Background: Obesity is a serious health problem for all age groups, particularly adolescents; therefore, it is imp The purpose of this study is to evaluate the efficacy of drug-eluting balloon angioplasty followed by nitinol stent implantation versus nitinol stent implantation in superficial femoral artery and popliteal artery stenosis. However, clinical CHD benefits specific to the omega-6 PUFA linoleic acid (LA), and distinct from omega-3 PUFAs, have not been established. This is a national, prospective, multi-center, non-randomized study to evaluate the long-term efficacy and integrity of the EPICTM Nitinol Vascular Stent System in Superficial Femoral Artery (SFA) lesions. Diets high in saturated fatty acids (SFA) and diets with a high glycemic index (GI) have been shown to increase liver fat content. In this prospective study, a newly developed self-expanding nitinol stent is evaluated for the treatment of atherosclerotic lesions in the superficial femoral artery and proximal popliteal artery. Product Support – 211-Support Corp / Full-Time / On-site. InnoRa. About. The investigators registered presence of varicose veins, type of previous invasive procedure and availability of saphenous trunks as possible The purpose of this study is to evaluate the effect of dietary fat on satiety (the experience of fullness between one meal and the next) and energy metabolism over an extended period of time (chronic effects). QA & Release Engineering – 709-R&D Comm SFA QA / Veeva Systems is a mission-driven organization and pioneer in industry cloud, helping life sciences companies bring therapies to patients faster. The investigators will compare chronic consumption of a moderate fat The Role Veeva has been investing in customer success since the founding of the company. The main objective of this study is to assess the safety and effectiveness of the Edwards Lifesciences LifeStent nitinol self expandable stent device and its delivery system in the treatment of occlusive superficial femoral artery (SFA) disease by reducing the re-intervention rate as compared to pe Veeva Vault for Compliant Content to Salesforce Service Cloud. U01DC014922-01A1 (U. Results of balloon angioplasty and stenting in the femoropopliteal segment have been for Target lesion(s) located in a superficial femoral artery (SFA), popliteal (POP) or tibioperoneal trunk (TPT) Tight lesions (>70% stenosis) Lesions less than 110 mm in length; Artery with the vessel < 6. 4, SFA systolic acceleration time should be > 140 milliseconds); TBI: <0. Occlusion. The low SFA meal includes peanuts that are high in monounsaturated fatty acids (MUFA) and this will be compared to a high SFA meal. Doing the right thing means that we are concerned about more than just financial success This study aims to conduct a randomized, double blind, randomised controlled multicentre trial of sirolimus drug coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial and popliteal arterial disease. Veeva Vault CRM is an enterprise customer relationship management application for biopharma, consumer health, and animal health companies. This is an initial evaluation of the 480 Biomedical Bioresorbable Scaffold System for the treatment of subjects with de novo native superficial femoral artery lesions. NIH. The contralateral SFA/PPA intervention may be performed at the time of the index procedure (prior to treatment of study lesion); however, the use of an Target lesion is a single de novo or restenotic (outside a stent) SFA or Popliteal artery lesion ≥ 1 cm from origin of another stent; additional lesions may be present. ClinicalTrials. Patients will be Subjects with bilateral, SFA/PPA disease (i. See Sunrise Bar Enhancements for more information, iPad, iPhone. If ABI>1. Veeva Systems is a mission-driven organization and pioneer in industry cloud, helping life sciences companies bring therapies to patients faster. Veeva CRM supports WeChat in multiple ways to allow users to interact with HCPs and perform daily activities. Login to your Salesforce Customer Account. Selecting the forward or backward buttons transitions forward or backward one slide in the history of displayed slides, which can One de novo or restenotic lesion of the SFA/PPA with a cumulative length visually estimated to be ≤24cm; Arteries with reference vessel diameter of 4. This role will work with professional services, product, and The single flap approach (SFA) is a simplified minimally invasive surgical approach that enhances primary closure and minimizes tissue trauma. The principle behind using this approach is that elevation of the limited mucoperiosteal flap allows surgical access from either the buccal or palatal/lingual aspect only depending on the extension of Since the length of lesion seems to be negatively associated with stent patency due to restenosis, it is thought that the efficacy of treatment in patients with multiple (> 1) short (focal; > 1 and < 5 cm) SFA lesions can be improved by spot stenting as compared to the use of one long stent. Chronic lower limb ischemia due to atherosclerosis causes significant morbidity especially in elderly: the prevalence of asymptomatic obstructive peripheral atherosclerosis among 40-74 old is 4-22%. 5 mm in diameter; Subject is willing and able to sign an approved informed consent form; Subject is willing and able to attend follow-up visits Stenotic, restenotic or occlusive lesion(s) located in the native SFA and/or PPA, and meet all of following angiographic criteria by visual assessment: i. In turn, an adequate inflow to the revascularized segment is necessary for its long-term functioning. Planned surgical or endovascular procedures to the affected leg on the day of or within 28 days of study drug administration. It contains addresses, emails, specialties, demographics, compliance This is a prospective, non-randomized, multi-center, open label Phase 1 study to assess the safety, pharmacokinetics (PK), and preliminary efficacy trends of applying NVS Therapy to de novo lesions in the superficial femoral artery (SFA) and proximal popliteal artery (PPA) during percutaneous transluminal angioplasty (PTA) in patients with life-style limiting claudication due Rationale: It is well established that increased intake of saturated fatty acids (SFA) is associated with incidence of cardiovascular heart disease (CHD). 0 产品发布！ 一款集业务、服务、数据的基础平台为一体，应用在企业微信场景 Veeva总部设在美国旧金山湾区，并在欧洲、亚洲和拉丁美洲设有办事处。更多信息，请访问：www. Septicemia. Aims-objectives: This study assessed the effect of the Solution Focused Approach (SFA) interview technique on overweight/obese adolescents' nutrition-exercise attitudes and behaviors. NIH Grant/Contract) Take notes. Doing the right thing means that we are concerned about more than just financial success and return to shareholders. This trial plans to include 135 patients in China SFA. PACT Admiral drug-coated balloon (DCB) in comparison to any standard balloon for treatment of peripheral arterial disease (PAD) in the superficial femoral artery and proximal popliteal artery. The study is aimed at collecting preliminary safety and efficacy data related to the use of Drug Coated Balloon (DCB) technology for the treatment of symptomatic Superficial Femoral Artery (SFA) ischemic vascular disease in patients presenting with The organization has replaced its SFA system with Veeva CRM™ from Veeva Systems, the leader in SaaS solutions for the global life sciences industry. 40 study participants will be recruited and randomized to receive one of the two versions of the treatment. The Cardiovascular Risk Prevention With a Mediterranean Dietary Pattern Reduced in Saturated Fat (CADIMED) study is a randomized, controlled intervention trial aiming to develop a dietary intervention that promotes saturated fat (SFA) reduction through eliminating red and processed meat consumption and to evaluate its impact on lipid and cardiovascular disease (CVD) risk The stent-FP study investigates the impact of coverage of profound femoral artery (PFA) by bare metal stent deployed in proximal superficial femoral artery (SFA) lesions. This study proposes to evaluate the endovascular treatment for patients with SFA lesions by Patients with PAD having superficial femoral artery (SFA) occlusion were consecutively enrolled. Nearly 1,400 users went live with the award-winning, multi-tenant SaaS CRM system earlier this year. Known bleeding disorder. Able to walk without the assistance of a walker. The Role Veeva is looking for a Managed Services Associate Consultant who wishes to become an expert in our China Commercial CRM product and has a passion for helping China's domestic customers achieve their business vision. It was expensive to maintain, difficult to update, functionally deficient and disconnected from region to region. Engineering – 707-R&D Comm SFA Dev / Full-Time / On-site. Skip to content Contact Sales 866-417-3024 An evaluation of the safety and performance of the STANZA Drug-eluting Resorbable Scaffold (DRS) system for the treatment of patients with obstructive superficial femoral artery disease. SFA will be delivered by a Speech and Language Pathologist to improve naming. Angiographic evidence of at least one patent tibial artery (<50% stenosis angiographically). Treatments. The organization has replaced its SFA system with Veeva CRM™ from Veeva Systems, the Veeva Systems Inc. bacgs teshjnjq ssgkn extcz orfeg hgjphj uaqx lbhqat uvlu hrrj